Resources
In a diagnostic clinical pathology laboratory, a technologist performs differential Gram staining followed by fluorescence in situ hybridization (FISH) on a synovial fluid aspirate from a patient with acute septic arthritis. The sample contains two cell populations: Host Inflammatory Cells (Population ) and Microbial Pathogens (Population ). Cell population averages to in diameter and shows multiple internal fluorophore-labeled rRNA puncta localized in the cytosol, bounded by an intact actin cytoskeleton. Cell population averages in diameter, stains Gram-positive purple, and binds specific rRNA oligonucleotide probes uniformly throughout its interior without compartmental partitioning. Categorize Population and Population as prokaryotic or eukaryotic, and explain why an antibiotic targeting the peptidoglycan cross-linking enzyme transpeptidase eliminates Population with zero mechanism-based cytotoxicity to Population .
Answer and steps
Final answer
Population is eukaryotic (human neutrophils/leukocytes); Population is prokaryotic (Gram-positive bacteria). Transpeptidase-inhibiting antibiotics (such as -lactams) exhibit selective toxicity because peptidoglycan and bacterial D-alanyl-D-alanine transpeptidases are strictly unique to prokaryotic cell wall synthesis and completely absent in eukaryotic human cells, which lack cell walls.
Steps
Categorize Population Based on Structural and Molecular Markers
- Size and Cytoskeleton: Population has a diameter of and contains an organized internal actin cytoskeleton. Typical eukaryotic animal cells range from , whereas prokaryotes are generally much smaller ().
- Ribosomal RNA Subunit: Population displays ribosomal RNA (rRNA). The rRNA is the signature structural RNA of the small () ribosomal subunit of eukaryotes (part of the complete ribosome).
Therefore, Population is eukaryotic (representing host inflammatory cells, such as neutrophils/leukocytes).
Categorize Population Based on Structural and Molecular Markers
- Size and Morphology: Population averages in diameter and lacks compartmentalized internal organelles.
- Cell Wall Characteristics: It retains Gram-positive crystal violet-iodine complexes (staining purple), indicating a thick, exterior meshwork of peptidoglycan.
- Ribosomal RNA Subunit: Population hybridizes with probes against rRNA distributed uniformly throughout the cytoplasm. The rRNA is a hallmark of the small () ribosomal subunit of prokaryotes (part of the complete ribosome).
Therefore, Population is prokaryotic (representing Gram-positive bacteria).
Explain the Basis of Selective Toxicity
- Target Mechanism: Bacterial transpeptidases (also known as penicillin-binding proteins, or PBPs) catalyze the final cross-linking step of adjacent peptide side-chains (specifically between and /diaminopimelic acid or lysine) during peptidoglycan cell wall biosynthesis.
- Antibiotic Action: -lactam antibiotics (such as penicillin or cephalosporin) mimic the terminal dipeptide, covalently binding and inactivating transpeptidase. This prevents cross-link formation, destabilizing the cell wall and causing osmotic lysis of actively dividing bacteria (Population ).
- Absence of Host Target: Animal eukaryotic cells (Population ) do not possess a cell wall, nor do they synthesize peptidoglycan or express transpeptidase enzymes.
Because the molecular target is entirely absent in human host cells, the drug exhibits selective toxicity, killing Population while causing zero mechanism-based cytotoxicity to Population .
Typical errors
01 The student misidentifies ribosomal subunit types by associating 16S rRNA with eukaryotic ribosomes and 18S rRNA with prokaryotes, reversing the cellular categories.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
Population X contains 18S rRNA and is prokaryotic. Population Y contains 16S rRNA and is eukaryotic.
CorrectPopulation X contains rRNA and is eukaryotic; Population Y contains rRNA and is prokaryotic.
You inverted the rRNA markers: rRNA is the characteristic component of eukaryotic small () ribosomal subunits, while rRNA is specific to prokaryotic small () ribosomal subunits.
- Step 2
Transpeptidase forms peptidoglycan cross-links in the bacterial wall.
- Step 3
Population X has a peptidoglycan wall and is eliminated by the drug, while Population Y lacks peptidoglycan.
CorrectPopulation Y has a peptidoglycan cell wall and is eliminated by transpeptidase inhibitors, whereas eukaryotic Population X lacks peptidoglycan entirely, resulting in zero mechanism-based cytotoxicity.
Because you reversed the cell identities in Step 1, you incorrectly assigned the peptidoglycan cell wall and drug susceptibility to Population X instead of Population Y.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly stated the biochemical role of transpeptidase in cross-linking bacterial peptidoglycan.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou associated rRNA with prokaryotes and rRNA with eukaryotes, reversing the cellular categories.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou confused the structural RNA components of prokaryotic ribosomes ( small subunit) with eukaryotic ribosomes ( small subunit).
REASONING PATH
Your ACEpath teacher’s suggested approach- Ribosomal Subunit Markers
Prokaryotic ribosomes () contain a small subunit harboring rRNA. Eukaryotic cytoplasmic ribosomes () contain a small subunit harboring rRNA.
Always pair rRNA with prokaryotes/bacteria and rRNA with eukaryotes.
- Corroborating Morphological Criteria
Eukaryotic cells are generally larger () and possess an internal actin cytoskeleton. Prokaryotes are smaller () and Gram stain according to their peptidoglycan wall.
Cross-check molecular markers with cell diameter ( for X vs for Y) to verify your classification.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify Population X (, actin cytoskeleton, rRNA) as eukaryotic.
Identify Population Y (, Gram-positive, rRNA) as prokaryotic.
Connect the drug mechanism: transpeptidase inhibitors selectively disrupt peptidoglycan cross-linking in prokaryotic walls (Population Y), sparing eukaryotic cells (Population X) which lack peptidoglycan entirely.
Population X is eukaryotic; Population Y is prokaryotic. The transpeptidase inhibitor specifically destroys Population Y because peptidoglycan cell walls are unique to prokaryotes and completely absent in eukaryotic host cells.
02 The student believes all cells contain peptidoglycan and assumes selective toxicity is due to differences in antibiotic transport or cell membrane permeability rather than the absence of the peptidoglycan target in eukaryotes.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
Population is eukaryotic due to rRNA and cytoskeletal structure. Population is prokaryotic due to rRNA and Gram-positive staining.
- Step 2
Inhibiting transpeptidase prevents peptidoglycan synthesis in the wall.
- Step 3
Population takes up the antibiotic directly across its porous wall, whereas the eukaryotic plasma membrane of Population blocks the antibiotic from reaching its peptidoglycan.
CorrectEukaryotic host cells (Population ) completely lack cell walls, peptidoglycan, and transpeptidase enzymes, so the drug has no molecular target in host cells.
Your explanation relies on differential membrane permeability, assuming host cells have peptidoglycan. Eukaryotic animal cells do not possess peptidoglycan or cell walls at all, which is the true basis for selective toxicity.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly classified Population as eukaryotic based on rRNA and an actin cytoskeleton.
You correctly classified Population as prokaryotic based on rRNA and Gram-positive staining.
You identified that transpeptidase functions in peptidoglycan synthesis.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou assumed that peptidoglycan is a universal cellular component present inside eukaryotic cells, attributing selective toxicity to differential membrane permeability rather than the complete absence of the drug target (peptidoglycan and transpeptidase) in animal cells.
REASONING PATH
Your ACEpath teacher’s suggested approach- Peptidoglycan Distribution
Peptidoglycan is uniquely synthesized by bacteria; animal cells have no cell wall and never produce peptidoglycan or transpeptidase enzymes.
Attribute -lactam selective toxicity to target absence in host cells, not to transport or membrane permeability barriers.
CORRECTED PATH
ACEpath Teacher's DemonstrationRecognize that human host cells (Population ) are animal cells and possess only a plasma membrane without any peptidoglycan cell wall.
Note that bacterial transpeptidases (penicillin-binding proteins) have no homologs or functional equivalents in human host cells.
Conclude that because the molecular target is entirely absent from Population , transpeptidase inhibitors cause zero mechanism-based toxicity to host cells.
Population is eukaryotic; Population is prokaryotic. Transpeptidase inhibitors selectively eliminate Population because peptidoglycan and transpeptidase are unique to bacterial cell wall biosynthesis and entirely absent in human eukaryotic cells.
03 The student confuses the mechanism of beta-lactam antibiotics targeting transpeptidase with translation inhibition at the ribosome.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
Population X is eukaryotic because it has 18S rRNA and cytoskeleton.
- Step 2
Population Y is prokaryotic because it has 16S rRNA and lacks compartmentalization.
- Step 3
The antibiotic binds to the 16S ribosomal subunit in Population Y to stop protein translation. Population X is unharmed because it uses 18S rRNA in its 80S ribosomes which cannot bind the drug.
CorrectTranspeptidase catalyzes the cross-linking of peptidoglycan side chains in bacterial cell wall synthesis (Population ), and inhibiting it causes cell wall destabilization and osmotic lysis. Population is completely unaffected because human host cells lack cell walls and do not express peptidoglycan or transpeptidase enzymes.
The prompt asked about an antibiotic targeting the cell wall enzyme transpeptidase, but you described an antibiotic that inhibits the ribosomal subunit ( rRNA).
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly identified Population as eukaryotic based on rRNA and an actin cytoskeleton.
You correctly identified Population as prokaryotic based on rRNA and the absence of compartmentalization.
You understood the broad principle of selective toxicity between prokaryotic and eukaryotic molecular targets.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou confused cell-wall-inhibiting antibiotics (transpeptidase/penicillin-binding protein inhibitors such as -lactams) with protein synthesis inhibitors that target the bacterial ribosomal subunit (such as aminoglycosides or tetracyclines).
REASONING PATH
Your ACEpath teacher’s suggested approach- Identify the Biochemical Target
Transpeptidases (PBPs) catalyze peptidoglycan transpeptidation in the bacterial cell wall, not protein translation at the ribosome.
Read the target enzyme specified in the prompt carefully before assigning an antibiotic mechanism of action.
- Link Target to Selective Toxicity
Selective toxicity relies on the total absence of the drug's target structure or pathway in the host cell.
Explain selective toxicity by stating that eukaryotic animal cells completely lack a peptidoglycan cell wall and its biosynthetic enzymes.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify the biochemical function of transpeptidase: it cross-links peptide chains between adjacent glycan polymers during peptidoglycan cell wall assembly.
Determine the consequence of inhibition in Population : blocking cross-linking weakens the bacterial peptidoglycan envelope, leading to osmotic lysis and cell death.
Determine why Population experiences zero mechanism-based cytotoxicity: eukaryotic host cells (human leukocytes) have no cell wall and synthesize zero peptidoglycan, meaning the molecular target is entirely absent.
Population is eukaryotic; Population is prokaryotic. The antibiotic inhibits transpeptidase, preventing peptidoglycan cross-linking and causing osmotic lysis in Population . Population is unharmed because animal cells lack cell walls and do not synthesize peptidoglycan.
Lock it in
Which specific ribosomal RNA (rRNA) molecule serves as the diagnostic marker for prokaryotic small ribosomal subunits versus eukaryotic cytosolic small subunits?
Prokaryotes contain rRNA (in the subunit); eukaryotes contain rRNA (in the subunit).
Similar question
A blood smear reveals an organism with a diameter of containing circular uncompartmentalized DNA and rRNA. Classify this cell as prokaryotic or eukaryotic, and state whether it would possess mitochondria.
Answer
Prokaryotic. It does not possess mitochondria because prokaryotes lack membrane-bound organelles.
An isolate of lung fluid reveals oval cells averaging in diameter containing a membrane-bound nucleus, rRNA, and a cell wall composed of chitin and -glucans. Categorize this organism and state whether penicillin (a transpeptidase inhibitor) would be effective against it.
Answer
Eukaryotic (fungal cell). Penicillin is completely ineffective because fungal walls contain chitin and glucans rather than bacterial peptidoglycan cross-linked by transpeptidase.
An antimicrobial peptide binds exclusively to bacterial lipid II and prevents the cross-linking catalyzed by transpeptidase. If applied to a co-culture of Staphylococcus aureus and human chondrocytes, predict the viability of each cell type and explain the biochemical basis.
Answer
Staphylococcus aureus will undergo cell lysis and die, while human chondrocytes remain fully viable. The biochemical basis is selective toxicity: human cells lack lipid II and a peptidoglycan cell wall entirely, so the drug has no target in host cells.